Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.
Verastem, Inc.
Intima Bioscience, Inc.
DualityBio Inc.
Lumicell, Inc.
DualityBio Inc.
GlaxoSmithKline
BicycleTx Limited
Revolution Medicines, Inc.
Bolt Biotherapeutics, Inc.
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Imugene Limited
Erasca, Inc.
Binhui Biopharmaceutical Co., Ltd.
NantBioScience, Inc.
Theseus Pharmaceuticals
Kyowa Kirin Co., Ltd.
InnoPharmax Inc.
Revolution Medicines, Inc.
Isofol Medical AB
Isofol Medical AB
Mirror Biologics, Inc.
Repos Pharma
Generic Devices Consulting, Inc.
FeRx